Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 121 - 140 out of 500 displayed.
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

MBX Biosciences Announces Pricing of Initial Public Offering

Read more ››
By: GlobeNewswire - 13 Sep 2024
Related companies:  Microbix Biosystems Inc.

Tammy Gold Rebrands as Therapeutic Parenting Method to Tackle Surgeon's Warning on Post-COVID Mental Health Challenges

Read more ››
By: PR Newswire Association LLC. - 13 Sep 2024

Halozyme Announces FDA Approval of Roche's Tecentriq Hybreza™ With ENHANZE® for Multiple Types of Cancer

Read more ››
By: PR Newswire Association LLC. - 13 Sep 2024
Related companies:  Halozyme Therapeutics

Bio-Me AS Announces Appointment of Arne Materna as Co-CEO alongside Dr. Warren Flood

Read more ››
By: PR Newswire Association LLC. - 13 Sep 2024
Related companies:  Bio-ME AS

Cytek Announces Resignation of Chief Operating Officer Chris Williams

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Cytek Biosciences Inc.

Fate Therapeutics to Present at 2024 Cantor Global Healthcare Conference

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Fate Therapeutics, Inc.

Celldex Therapeutics to Present at Upcoming Investor Conferences

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Celldex Therapeutics, Inc.

NurExone Biologic Extends Global Reach with Presentations at Industry-Leading Conferences

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  NurExone Biologic Ltd.

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Ocular Therapeutix, Inc.

One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All Populations

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  23andMe, Inc.

Tilray Brands Completes Acquisition of Atwater Brewery From Molson Coors Beverage Company

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Tilray Inc.

Generation Bio to Present at the 2024 Cantor Global Healthcare Conference

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Generation Bio Co.

QIAGEN and Bio-Manguinhos/Fiocruz collaborate to enhance malaria and dengue detection in Brazil’s national screening programs

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Qiagen NV

Cidara Therapeutics Restructures Workforce to Focus on Planned Clinical Development of CD388

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Cidara Therapeutics, Inc.

AVITA Medical to Present at 2024 Cantor Global Healthcare Conference

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  AVITA Medical, Inc. | Avita Medical Ltd

Immuneering Announces Positive Initial Phase 2a Data Including Complete and Partial Responses with IMM-1-104 in Combination with Chemotherapy in First-Line Pancreatic Cancer Patients

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Immuneering Corporation

Immunocore to present at the 2024 Cantor Global Healthcare Conference

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Immunocore Limited

Valneva Announces the Launch of a Private Placement of Ordinary Shares for Approximately 60 Million Euros

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Valneva SE

Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Lifecore Biomedical, LLC

Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Avid Bioservices, Inc.
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑